Elekta AB (OSTO:EKTA B) ROCE % : 12.77% (As of Jan. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Elekta AB ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Elekta AB's annualized ROCE % for the quarter that ended in Jan. 2024 was 12.77%.

Elekta AB ROCE % Historical Data

The historical data trend for Elekta AB's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB ROCE % Chart

Elekta AB Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

ROCE %

Get a 7-Day Free Trial

14.31

11.39

12.41

11.93

9.00

Elekta AB Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
ROCE %	Get a 7-Day Free Trial															12.13	10.96	10.27	13.17	12.77

Elekta AB ROCE % Calculation

Elekta AB's annualized ROCE % for the fiscal year that ended in Apr. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Apr. 2023 )		(A: Apr. 2022 )		(A: Apr. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Apr. 2023 )		(A: Apr. 2022 )		(A: Apr. 2023 )
	=	1424	/	( ( (26303 - 11556)	+	(29608 - 12706) )	/ 2 )
	=	1424	/	( (14747	+	16902)	/ 2 )
	=	1424	/	15824.5
	=	9.00 %

Elekta AB's ROCE % of for the quarter that ended in Jan. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jan. 2024 )		(Q: Oct. 2023 )		(Q: Jan. 2024 )
	=	2272	/	( ( (31614 - 13799)	+	(30731 - 12972) )	/ 2 )
	=	2272	/	( ( 17815	+	17759 )	/ 2 )
	=	2272	/	17787
	=	12.77 %

(1) Note: The EBIT data used here is four times the quarterly (Jan. 2024) EBIT data.

Elekta AB (OSTO:EKTA B) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Elekta AB ROCE % Related Terms

Thank you for viewing the detailed overview of Elekta AB's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Elekta AB (OSTO:EKTA B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OSTO:EKTA B) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

EKTAY:USA EKTAF:USA EKTAB:Mexico EKTABs:UK 0O5H:UK EJXB:Germany

Address

Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93

Website

https://www.elekta.com

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.

Elekta AB (OSTO:EKTA B) Headlines

No Headlines